Objective To determine the impact of a cerebrospinal fluid enterovirus polymerase chain reaction (PCR) test performance on hospital length of stay (LOS) in a large multicenter cohort of infants undergoing evaluation for central nervous system infection.
Results Of 19 953 hospitalized infants, 4444 (22.3%) had an enterovirus PCR test performed and 945 (21.3% of tested infants) had positive test results. Hospital LOS was similar for infants who had an enterovirus PCR test performed compared with infants who did not (incident rate ratio 0.98 hours; 95% CI 0.89-1.06). However, infants PCR positive for enterovirus had a 38% shorter LOS than infants PCR negative for enterovirus (incident rate ratio 0.62 hours; 95% CI 0.57-0.68). No infant with a positive enterovirus PCR test had bacterial meningitis (0%; 95% CI 0-0.4).
Conclusions Although enterovirus PCR testing was not associated
with a reduction in LOS, infants with a positive enterovirus PCR test had a one-third shorter LOS compared with infants with a negative enterovirus PCR test. Focused enterovirus PCR test use could increase the impact on LOS for infants undergoing cerebrospinal fluid evaluation. Y oung infants brought to the emergency department (ED) for evaluation of fever are frequently hospitalized and treated with parenteral antibiotics while awaiting bacterial culture results. 1, 2 However, the majority of febrile infants have viral infections and require only supportive care. 1, 3 Distinguishing between viral and bacterial infections using clinical and laboratory findings available at the time of initial evaluation presents challenges. 1, 4 Enterovirus, a common cause of fever in young infants, [5] [6] [7] can be detected in the cerebrospinal fluid (CSF) by a reverse transcriptase polymerase chain reaction (PCR), 8, 9 with results often available within a few hours. 7, 10 Previous studies have suggested that children with enteroviral infections are at low risk of bacterial co-infection. 5, 11 Rapid diagnosis of enteroviral infection may reduce the duration of hospitalization for febrile infants by identifying infants at very low risk of invasive bacterial infections (eg, bacteremia and acute bacterial meningitis). A positive enterovirus PCR test has been associated with a shorter duration of hospital stay and of parenteral antibiotics, 7, 10, 12, 13 which may result in reduced healthcare costs, 14 
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infections and medication errors), and reduced burden on families. However, previous investigations have been singlecenter studies and included few infants with bacterial meningitis, reducing generalizability and clinical applicability. Additionally, prior studies have not evaluated the impact of performing an enterovirus PCR test on hospital length of stay (LOS).
To address these limitations, we assembled a large, multicenter, retrospective cohort of hospitalized infants ≤60 days of age who had a CSF culture obtained as part of the ED evaluation. Our aims were to determine the association between performance of an enterovirus PCR test and hospital LOS as well as between a positive enterovirus PCR test result and hospital LOS.
Methods
We performed a planned secondary analysis of a retrospective cohort study of infants ≤60 days of age who were brought to the ED and underwent evaluation for central nervous system infection. The parent study, designed to determine the prevalence of herpes simplex virus infection, was endorsed by the Pediatric Emergency Medicine Collaborative Research Committee and included 23 hospitals. We limited this analysis to the 18 participating hospitals that contributed LOS and enterovirus PCR data. The institutional review board at each participating institution approved the study protocol, with a waiver of informed consent and permission for data sharing.
We identified infants ≤60 days of age who were brought to the ED of a participating institution between January 1, 2005, and December 31, 2013, and in whom a CSF culture was obtained in the ED or within 24 hours of ED arrival. The exact study period varied somewhat between participating institutions based on available electronic data sources. Eligible infants were identified at each site using a site-specific electronic search strategy. Infants could be included more than once if they had multiple eligible ED encounters. For this study, we excluded infants who were discharged from the ED after initial evaluation or who were missing hospital LOS data.
The following data elements were extracted either electronically or manually from existing medical records at each participating site: date of visit, ED arrival time, demographics, disposition (discharge vs admission and, for admitted infants, floor vs intensive care unit), ED triage temperature, hospital discharge date and time, and laboratory data (urinalysis, complete blood count with differential, and CSF cell count, glucose, protein, and Gram stain). We also extracted results of blood, urine, and CSF bacterial cultures and the CSF enterovirus PCR test. Because the enterovirus PCR test is currently only approved by the US Food and Drug Administration for testing CSF, we did not extract data related to the use of this PCR test on nonapproved sample types. 15 Infants with a positive enterovirus PCR test result were classified as having an enteroviral infection. We defined an invasive bacterial infection as growth of pathogenic bacteria from blood or CSF culture. Serious bacterial infection was defined by the presence of any invasive bacterial infection or a urinary tract infection 16 defined as a catheterized urine culture with ≥50 000 colony-forming units/mL of a single pathogenic bacteria or 10 000-50 000 colony-forming units/mL of a single pathogenic bacteria with an abnormal urinalysis (i.e., positive nitrite or leukocyte esterase test on urine dipstick or >5 white blood cells per high-power field on urine microscopy). 17, 18 Cultures from which >1 bacterial species were isolated were considered contaminated unless ≥1 was a true pathogen. We defined a priori as contaminants normal skin or oral flora isolated from a bacterial culture of urine, blood, or CSF (Table I ; available at www.jpeds.com).
The primary outcome measure was hospital LOS defined as the time from ED arrival to provider signature of the hospital discharge order.
Statistical Analyses
The unit of analysis was the ED encounter. We described categorical variables using counts and proportions with 95% CI, and compared using the c 2 test. We described continuous variables using medians and IQR, and compared using the MannWhitney U test. We examined trends over time using the Mantel-Haenszel trend test.
We used quantile regression models to compare median LOS between groups. We also estimated negative binomial regression models to compare LOS counts between groups, adjusting for patient age and study year after clustering by center. These negative binomial models also used a robust variance estimator to accommodate the correlation resulting from the clustering of patients within hospitals. The output of the negative binomial model was an incident rate ratio, which is the ratio of LOS by hour between the comparison groups. We first compared infants with and without an enterovirus PCR test performed. Next, for the subgroup of infants who had the enterovirus PCR test performed, we compared LOS for infants with a positive vs negative enterovirus PCR test result. Owing to differential clinical management, 19, 20 we also stratified each comparison by patient age (≤28 days vs 29-60 days) and by CSF pleocytosis (present vs absent). We defined CSF pleocytosis using published age-based normal values: CSF white blood cells ≥20 cells/mm 3 for infants ≤28 days of age and ≥10 cells/ mm 3 for infants 29-60 days of age. 21 We also examined the use and impact of enterovirus PCR testing by participating hospital center and over the study period. We examined the relationship between the rate of enterovirus PCR testing and percent positivity using a Spearman correlation coefficient.
We Figure 2 ). The enterovirus PCR testing rate increased over the study period from 10.9% in 2005 to 24.6% in 2013 (P = .003). Centers with higher enterovirus PCR testing rates had lower positive test rates (Spearman coefficient −0.5; 95% CI −0.1 to −0.8; Figure 3 ; available at www.jpeds.com).
Next, we compared infants who had an enterovirus PCR test performed with those who did not have the test performed. Infants who were seen during peak enteroviral season or who had CSF pleocytosis were more likely to have an enterovirus PCR test performed (Table II) . Overall, 1710 infants (8.6%) had any serious bacterial infection, and 557 (2.8%) had an invasive bacterial infection, of which 182 (0.9%) had bacterial meningitis. Compared with infants with a positive enterovirus PCR test result, infants with a negative test result had higher rates of both any serious bacterial infection (6.2% vs 0.8%; difference 5.4%; 95% CI 4.3-6.3%) as well as invasive bacterial infection (2.5% vs 0.4%; difference 2.1%; 95% CI 1.3-2.7). Of the 945 infants with a positive enterovirus PCR, 8 had a concomitant serious bacterial infection (0.8%; 95% CI 0.4-1.7). Of these, 4 had an invasive bacterial infection, all of which were bacteremia (0.4%; 95% CI 0.2-1.1) and none was bacterial meningitis (0%; 95% CI 0.0-0.4). The bacteremia pathogens isolated were: Staphylococcus aureus (n = 2), Escherichia coli (n = 1), and Klebsiella sp. (n = 1).
Of the 4087 infants with CSF pleocytosis, 1163 (28.5%) had an enterovirus PCR test performed. Older infants 29-60 days of age with CSF pleocytosis had higher enterovirus PCR testing rates (664/2149 [30.9%]) when compared with infants ≤28 days Overall, the median LOS was 2.4 days (IQR 1.9-3.3). Infants who had an enterovirus PCR test performed had only a slightly shorter LOS than those who did not have an enterovirus PCR test performed (Table III) . Of the 4444 infants who had an enterovirus PCR test performed, infants with a positive test result had a 0.4-day shorter LOS (95% CI 0.3-0.5) compared with those with a negative test. We observed a similar impact of a positive enterovirus PCR test in the older infants aged 29-60 days and in those with CSF pleocytosis. When the analysis was limited to infants without a serious bacterial infection, infants with a positive enterovirus PCR test had a 0.4 day shorter LOS (95% CI 0.3-0.4) compared with infants with a negative test.
After adjusting for study year and patient age as well as clustering by center (Table III) , hospital LOS was similar for infants who had an enterovirus PCR test performed compared with those who did not undergo testing (incident rate ratio 0.98 hours; 95% CI 0.89-1.06). However, for infants who had an enterovirus PCR test performed, infants with a positive test result had a 38% shorter LOS compared with those with a negative test result (incident rate ratio 0.62 hours; 95% CI 0.57-0.68).
Discussion
In this multicenter cohort of nearly 20 000 hospitalized infants ≤60 days of age, enterovirus PCR testing was obtained in almost one-quarter of infants. Overall, the performance of the enterovirus PCR test did not shorten hospital LOS. However, infants with a positive enterovirus PCR test had an approximately one-third shorter LOS after adjustment for patient age and study year, and clustering by hospital center. Similar to studies of older children, 11 no child with a positive enterovirus PCR test had bacterial meningitis.
Our results are consistent with previous studies demonstrating an association between a positive enterovirus PCR test result and a reduction in hospital LOS. 7, 10, 12, 13, 22 Our study expands on previous findings in several important ways. First, prior investigations each were conducted at a single center, where clinical care could have been more determined by protocol. 23 Our study demonstrates the impact of a positive enterovirus PCR test result across clinical settings, which increases the generalizability of our findings. Second, our substantially larger sample size allowed stratification of results by patient age (infants ≤28 days vs 29-60 days) as well as by the presence of CSF pleocytosis. Third, we examined the overall impact of the decision to obtain an enterovirus PCR test in infants undergoing evaluation for central nervous system infection. This assessment is critical, because diagnostic tests have both high-value as well as low-value applications in practice. 24 At the patient level, although we observed a statistically significant reduction in LOS for infants who had an enterovirus PCR test performed compared with those who did not, the small reductions were of uncertain clinical significance and disappeared after adjustment for patient age and study year, and when clustering by center. Our study highlights the importance of targeting enterovirus PCR testing to infants most likely to have a positive test and who could be candidates for early discharge if the enterovirus PCR test was positive. Otherwise, the costs savings from earlier hospital discharge may be outweighed by increased costs of additional viral testing.
Enterovirus PCR is the diagnostic gold standard to confirm enterovirus infection of the central nervous system. Enterovirus PCR testing technology has changed over the past 2 decades, with test results now available in a clinically relevant timeframe. Commercially available enterovirus PCR 25, 26 However, in practice, test turnaround time typically ranges between 12 and 24 hours, reflecting limited testing hours and specimen batching. 7, 10, 13 As clinical enterovirus PCR testing evolves, earlier availability of test results may increase the impact on LOS.
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The risk of bacterial meningitis in infants with a positive enterovirus PCR test result is low. In a previous study of 735 children ≤18 years of age with meningitis and a positive enterovirus PCR test, none had bacterial meningitis (0%; 95% CI 0.0-0.4). 11 Our study confirmed that the risk of bacterial meningitis is low in the youngest infants. None of the 945 study infants with a positive enterovirus PCR test had bacterial meningitis. Given the low risk of co-infection, particularly bacterial meningitis, clinicians can safely consider outpatient management strategies for infants with a positive enterovirus PCR test result. For those infants initially hospitalized, the majority of blood and CSF bacterial cultures that yield growth of a pathogenic organism are positive within 24 hours, 27, 28 although CSF cultures may be assessed for growth once daily at some microbiology laboratories. Therefore, an infant with a positive enterovirus PCR test and negative bacterial cultures of the blood and CSF at 24 hours is at extremely low risk for co-infection, allowing for safe earlier hospital discharge. Treating clinicians must also consider the infant's clinical status and results of other laboratory tests before making management decisions.
The optimal enterovirus PCR testing strategy for febrile infants undergoing evaluation for central nervous system infection needs to be determined. In our study, centers with higher enterovirus PCR testing rates had a lower proportion of positive tests. A prior cost analysis found that enterovirus PCR testing for infants with CSF pleocytosis would reduce healthcare costs if the prevalence of enteroviral infection was >6%, assuming that infants with a positive test were discharged 24 hours after hospitalization.
14 In our study, >20% of infants tested had a positive enterovirus PCR, which exceeded this threshold. However, more than one-half of the infants with a positive enterovirus PCR test result had a LOS of ≥2 days. The observed reductions in LOS were greatest for the infants with CSF pleocytosis, although almost three-quarters of these infants did not have an enterovirus PCR test obtained. Even during the peak enteroviral season, 60% of infants with CSF pleocytosis did not have an enterovirus PCR test performed, even though one-half of the tested infants had a positive result. Targeted use of the enterovirus PCR test (eg, for infants with CSF pleocytosis or during annual peak enteroviral season) and rapid turnaround time likely would increase the test's impact on hospital LOS.
Our study has several limitations. First, our study was conducted at North American children's hospitals, and may not be generalizable to other settings. Second, we were unable to determine the timing of enterovirus PCR result availability to the clinical team, which may have varied between participating institutions and over the study period. Third, we relied on the time that the treating clinician signed the discharge order to calculate the hospital LOS. Although some infants may have lingered in the hospital while awaiting a caregiver's arrival or for transportation home, the order was signed when the clinical team judged the infant appropriate for home management.
Fourth, we do not have data on the infants' clinical appearance and ill-appearing infants would have a longer hospital LOS, regardless of the enterovirus PCR test result. Although we examined intensive care unit admission as a proxy measure, admission location for neonates varies across centers and, therefore, may not reflect illness severity. Fifth, we were unable to determine which infants had received antibiotics before performance of the diagnostic lumbar puncture, potentially rendering bacterial cultures falsely negative. 29 However, we do know that the youngest infants with fever are infrequently pretreated with antibiotics. 16, 18 Sixth, enterovirus PCR testing decisions were at the discretion of the clinical team. Although we adjusted for patient age and study year, and clustering by center, we cannot fully control for clinical differences between tested and untested infants, raising the potential for unadjusted confounding. Last, we excluded infants who were discharged from the ED. In the future, enterovirus PCR testing platforms with very rapid test turnaround times (eg, as little as 1 hour) may provide results while the patient is still in the ED, which may reduce rates of hospitalization altogether in certain patients. ■ 
